Featured Education

Breathing Easy: Improving Collaboration Amongst Multidisciplinary Teams to Tackle OSA

Click here to learn more

The Evolution of HCT

Click here to learn more

Breathing Easy: Screening and Management of OSA

Click here to learn more

Breathing Easy: The Interconnection of OSA and Disease-related Complications

Click here to learn more

Build Your Own Case Study | From Evidence to Practice: Enhancing T2D Outcomes with Informed Approaches on Obesity

Click here to learn more

Dermatology Dialogues: Enhancing Patient Quality of Life

Click here to learn more

On Demand Activities

More results...

Therapeutics Areas
Learner Specialties
Expires After
  • On-Demand
Breathing Easy: Conquering Obstructive Sleep Apnea for Better Health - Improving Collaboration Amongst Multidisciplinary Teams to Tackle OSA
  • Credit: 0.50hr(s)
  • AAFP, AAPA, CME, MOC
  • March 6, 2024 — 
  • March 5, 2025
  • Therapeutic Areas: Family Medicine / Primary Care
  • Location: Internet Activity Enduring
Obstructive Sleep Apnea (OSA) is a prevalent but often underestimated sleep disorder with significant implications for the health and well-being of individuals in the United States. Despite its impact on chronic diseases and healthcare costs, OSA remains underdiagnosed, leading to untreated sleep apnea and its consequences. With emerging strategies for OSA treatment, it’s crucial for healthcare providers to stay informed about the latest clinical evidence shaping the treatment landscape.
Access Course
  • On-Demand
New Horizons in Multiple Myeloma Treatment: The Promise of CAR-T for Early Relapsed Disease
  • Credit: 1.00hr(s)
  • AAPA, CME, CPE, IPCE, NCPD
  • May 31, 2023 — 
  • May 30, 2024
  • Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
  • Specialties: CAR T-Cell Therapy, Multiple Myeloma
  • Location: Internet Activity Enduring
Despite remarkable progress, significant gaps remain in meeting the needs of patients facing relapse in multiple myeloma, particularly among patients with early relapse or triple-class exposed disease. Join us for a groundbreaking Special Edition Med Table Talk episode where we delve into the latest advancements in the treatment of relapsed multiple myeloma (RRMM).  This candid conversation between esteemed faculty experts discusses the latest clinical evidence and rationale for CAR T-cell therapy in early versus late relapse settings and embraces a future pathway where highly effective treatments may be delivered earlier to support increasingly durable responses for complex patient populations.
Access Course
  • On-Demand
Dermatology Dialogues | Gaining and Maintaining Flare Control in Moderate-to-Severe Atopic Dermatitis: Enhancing Patient Quality of Life
  • Credit: 1.0hr(s)
  • AAPA, ABIM, CME, IPCE, MOC
  • December 22, 2023 — 
  • December 21, 2024
  • Therapeutic Areas: Allergy, Dermatology
  • Specialties: Atopic Dermatitis
  • Location: Internet Activity Enduring
This 4 part-15 minute segmented vodcast/podcast will unite dermatology and allergy clinicians, who provide care for patients with moderate-to-severe atopic dermatitis (M-S AD).
Access Course
  • On-Demand
Build Your Own Case Study | From Evidence to Practice: Enhancing T2D Outcomes with Informed Approaches on Obesity
  • Credit: 0.98hr(s)
  • AAPA, CME, EBAH, ECMEC, IPCE, MOC, NCPD
  • January 15, 2024 — 
  • January 14, 2025
  • Therapeutic Areas: Diabetes, Endocrinology
  • Specialties: Diabetes, Endocrinology, Obesity, Primary Care
  • Location: Internet Activity Enduring
The tie between type 2 diabetes (T2D) and overweight/obesity is a significant global public health issue, supported by decades of extensive research. Despite formal clinical guidelines recommendations in addressing both diseases, the initiation or intensification of therapies that improve glycemic control and achieve weight reduction targets are slowly adopted into clinical practice, particularly for patients with T2D. Given the overlap of these two conditions, it is imperative that healthcare providers worldwide align clinical practice with evidence-based guidelines and the latest clinical findings using newer agents to treat both diseases.
Access Course
  • On-Demand
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Real-world Applications in Clinical Practice / Activity 2
  • Credit: 0.50hr(s)
  • AAPA, CME, CPE, NCPD
  • February 17, 2023 — 
  • September 30, 2024
  • Therapeutic Areas: Hematologic Oncology, Oncology
  • Specialties: NSCLC, Oncology
  • Location: Internet Activity Enduring
This educational initiative is designed for community-based oncology clinicians (physicians, nurse practitioners [NPs], physician assistants [PAs], pharmacists, and nurses) to enhance outcomes for individuals with who provide care for individuals with mNSCLC. This interactive online activity uses the game-based platform Kahoot! to test participant ability to identify and apply key learning points to metastatic NSCLC (mNSCLC) patient cases while competing against their colleagues. Expert faculty will discuss the emerging efficacy and safety data for CTLA-4 inhibitor combination regimens in mNSCLC and explore strategies to identify patients who would most benefit from these therapies through the use of biomarkers. Additionally, there will be an in-depth discussion regarding approaches to effectively collaborate with other clinicians and mNSCLC patients to provide cost-effective, equitable, and inclusive care for patients of all socioeconomic and racial/ethnic backgrounds. Join us for Part 1 of this question and answer based educational activity, Improving Survival in First-line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies for an in-depth dive into the data!
Access Course
  • On-Demand
Breathing Easy: Conquering Obstructive Sleep Apnea for Better Health - Screening and Management of OSA
  • Credit: 0.50hr(s)
  • AAFP, AAPA, CME, MOC
  • February 21, 2024 — 
  • February 20, 2025
  • Therapeutic Areas: Family Medicine / Primary Care
  • Location: Internet Activity Enduring
Obstructive Sleep Apnea (OSA) is a prevalent but often underestimated sleep disorder with significant implications for the health and well-being of individuals in the United States. Despite its impact on chronic diseases and healthcare costs, OSA remains underdiagnosed, leading to untreated sleep apnea and its consequences. With emerging strategies for OSA treatment, it’s crucial for healthcare providers to stay informed about the latest clinical evidence shaping the treatment landscape. Explore the 3-part on-demand series, Breathing Easy: Conquering Obstructive Sleep Apnea for Better Health. This collaborative effort, in conjunction with local AAFP Chapter meetings, provides expert guidance and clinical best practices for screening, managing, monitoring, and treating patients with OSA
Access Course
View All MLI Activities
Facebook Twitter Linkedin Instagram
Subscribe to Mailing List
Scroll to Top